High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma.
Magagnoli
Massimo
M
Balzarotti
Monica
M
Siracusano
Licia Vanessa
LV
Spina
Michele
M
Isa
Luciano
L
Morenghi
Emanuela
E
Tirelli
Umberto
U
Santoro
Armando
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D012008:Recurrence
D001761:Bleomycin; D015251:Epirubicin; D005047:Etoposide; D003520:Cyclophosphamide; D011241:Prednisone